Dogwood Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Dogwood Therapeutics, Inc. (DWTX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 8.33 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-12
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 8.33M shares, a 72.38% increase year-over-year.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 8.33M shares, a 72.38% increase year-over-year.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 8.33M shares, a 72.29% increase year-over-year.
- Dogwood Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 4.83M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month |
|---|---|---|---|
| 2021-09-30 | 8.33M shares 10-Q · filed 2021-11-12 | 8.33M shares derived: average of 2 quarters · filed 2021-11-12 | 8.33M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 8.33M shares 10-Q · filed 2021-08-13 | 8.33M shares 10-Q · filed 2021-08-13 | |
| 2021-03-31 | 8.33M shares 10-Q · filed 2021-05-14 | ||
| 2020-09-30 | 4.83M shares 10-Q · filed 2021-11-12 | 4.83M shares derived: average of 2 quarters · filed 2021-11-12 | 4.83M shares 10-Q · filed 2021-11-12 |
| 2020-06-30 | 4.83M shares 10-Q · filed 2021-08-13 | 4.83M shares 10-Q · filed 2021-08-13 | |
| 2020-03-31 | 4.83M shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |